RefinedPractice
OHE has an Opening for an Industrial Economist
20 November 2019
The Office of Health Economics wishes to recruit a well-qualified, highly motivated and energetic economist with an industrial organisation background applied to the health care sector,…
Press Release: Proposed International Price Index Effectively Outsources Pharmaceutical Policy Decisions to Other Countries
29 October 2019
New research by the Office of Health Economics (OHE) concludes the proposed International Price Index effectively outsources pharmaceutical policy decisions to countries that “give the government…
NICE and EuroQol Research Foundation to Support New EQ-5D-5L Valuation Study
24 October 2019
As indicated in its recent statement, NICE supports a new valuation study to generate a value set for the EQ-5D-5L. We welcome this announcement. As indicated…
Chronic Diseases and the Stock of Health: Quantification Using EQ-5D-5L
15 October 2019
Chronic diseases affect individuals’ health status and its impact is reflected by the stock of health, which measures the amount of health of a population in…
Patient Preferences for Diagnostic Tests Aimed at Managing Antimicrobial Resistance
7 October 2019
Research by OHE and the University of Sussex into patients’ preferences for diagnostic tests aimed at reducing antimicrobial resistance has been published in Applied Health Economics…
Making Outcome-based Payment a Reality in the NHS: Moving to the Next Phase
3 October 2019
OHE, in collaboration with RAND Europe, University College London (UCL) and University of Manchester (UoM), has been awarded a new research grant from Cancer Research UK…
Can Conventional Blood Tests Predict Future Disability Risks?
25 September 2019
New research published in Economics and Human Biology demonstrates that elevated blood tests and nurse-collected physical measures predict progression to disability two to four years ahead…
HTA and Payment Mechanisms for New Drugs to Tackle AMR
23 September 2019
A new OHE Research Paper summarises the findings of a project funded by the Wellcome Trust on innovative HTA methods and contracting for antibiotics. The paper…
A Market-based International Reference Price Index: Solution or Contradiction?
13 September 2019
The Trump Administration proposed an International Pricing Index for reimbursing physician-administered Medicare drugs. A conservative thought leader proposed a different basket of ‘market-oriented’ countries. These differ…